Use of real-world evidence in cancer drug funding decisions in Canada: a qualitative study of stakeholders’ perspectives

BACKGROUND: Real-world evidence (RWE) can provide postmarket data to inform whether funded cancer drugs yield expected outcomes and value for money, but it is unclear how to incorporate RWE into Canadian cancer drug funding decisions. As part of the Canadian Real-World Evidence Value for Cancer Drug...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:CMAJ Open
Asıl Yazarlar: Clausen, Marc, Mighton, Chloe, Kiflen, Ruhi, Sebastian, Agnes, Dai, Wei Fang, Mercer, Rebecca E., Beca, Jaclyn M., Isaranuwatchai, Wanrudee, Chan, Kelvin K.W., Bombard, Yvonne
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Joule Inc. or its licensors 2020
Konular:
Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7721249/
https://ncbi.nlm.nih.gov/pubmed/33234584
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.9778/cmajo.20200118
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller